Supported by

TAVI (Transcatheter aortic valve implantation)

Latest TAVI content in interventional cardiology - research, practice, and education

TAVI, now an established, valid treatment for patients presenting with symptomatic severe aortic stenosis, has proven to be superior to medical treatment for inoperable patients whilst being a valid alternative to surgery in select, high-risk patients. This topic covers the newest devices and emerging data in TAVI as well as information on tools, devices and techniques such as vascular access; the role of adjunctive pharmacotherapy; imaging techniques such as echocardiography, understanding bleeding risks or patient selection. Use the filters below to access PCRonline resources.

Anatomy of the aortic valvar complex

View a detailed and comprehensive description of the anatomy of the aortic valvar complex as it pertains to TAVI.

View illustrated aortic valvar complex

Filtered By
TAVI

1364 results

Prevention and management of TAVI complications

14 Feb 2026 – From PCR Tokyo Valves 2026

This session addresses the prevention and management of major complications associated with transcatheter aortic valve implantation (TAVI). Attendees will gain a detailed understanding of mechanisms behind cerebral infarction, haemolysis, valve infolding, pacemaker implantation, and valve migration, along with expert strategies for recognition, decision-making, and bailout techniques...

Prevention and management of TAVI complications

Procedural optimisation for enhanced acute and long-term outcomes

14 Feb 2026 – From PCR Tokyo Valves 2026

This session emphasizes procedural optimization in TAVI to enhance both acute and long-term outcomes. It highlights critical factors such as valve sizing, expansion, implantation depth, and commissural alignment. Practical techniques for pre- and post-dilatation alongside commissural alignment are demonstrated through real cath lab cases, underscoring their...

Procedural optimisation for enhanced acute and long-term outcomes

TAVI: new evidence and clinical trials

14 Feb 2026 – From PCR Tokyo Valves 2026

This session reviews the latest evidence from head-to-head clinical trials comparing contemporary TAVI devices, including detailed discussions of the LANDMARK and COMPARE trials. It also highlights ongoing and upcoming clinical trials poised to influence guideline recommendations and expand the therapeutic scope of TAVI, providing crucial insights...

TAVI: new evidence and clinical trials

Team approach to structural heart disease: how to handle unexpected situations

14 Feb 2026 – From PCR Tokyo Valves 2026

This session highlights the multidisciplinary team approach to managing structural heart disease, focusing on responses to unexpected intraoperative and postoperative situations. It features real-world experiences from a TAVI radiologic technologist, clinical engineer, TEER sonographer, and TEER nurse, emphasizing their respective roles in addressing intraoperative events, sudden...

Team approach to structural heart disease: how to handle unexpected situations

TAVI today and tomorrow: international trends and future direction

14 Feb 2026 – From PCR Tokyo Valves 2026

This session focuses on the evolving landscape of TAVI, emphasising lifetime management strategies with a focus on the first valve implanted. It provides a comprehensive discussion on representative patient profiles, current guidelines from various countries, and future outlooks, alongside recent long-term clinical results for the balloon-expandable...

TAVI today and tomorrow: international trends and future direction

Built to last: lifetime management for durability and beyond

14 Feb 2026 – From PCR Tokyo Valves 2026

This session addresses the principles of lifetime management aimed at durability and optimal long-term outcomes in complex valvular heart disease cases. Key topics include the critical importance of initial valve choice, practical tips for optimizing paravalvular leak (PVL) management, and advanced strategies for redo transcatheter aortic...

Built to last: lifetime management for durability and beyond

Protect the brain for TAVI - True potential of SENTINEL Cerebral Protection System

14 Feb 2026 – From PCR Tokyo Valves 2026

This session highlights the critical role of cerebral protection during TAVI procedures by focusing on the SENTINEL Cerebral Protection System. It reviews trends in the United States and Japan, presents clinical outcomes one year post-introduction in Japan, and examines key clinical trials through a meta-analysis comparing...

Protect the brain for TAVI - True potential of SENTINEL Cerebral Protection System

Patient-tailored treatment for bicuspid valve

14 Feb 2026 – From PCR Tokyo Valves 2026

Delve into patient-tailored treatment strategies for bicuspid aortic valve stenosis, focusing on evidence-based valve selection and sizing for TAVI candidates. This session reviews current device options, procedural planning considerations, and case studies illustrating the use of balloon-expanding and self-expanding valves, emphasizing challenges posed by unfavourable bicuspid...

Patient-tailored treatment for bicuspid valve

Mitral and aortic transcatheter valve-in-valve intervention - LIVE case

14 Feb 2026 – From PCR Tokyo Valves 2026

Live case
An 83-year-old male with AF, CKD (stage 3A), preserved LV function, and a history of AVR (27 mm Magna Ease) and MVR (33 mm Magna) in 2014 presented with symptomatic stenosis of the mitral bioprosthesis. A Sapien 3 valve was implanted in the Magna mitral...

Mitral and aortic transcatheter valve-in-valve intervention - LIVE case

Learn from the experts: lifetime management for Evolut first redo TAVI (TAV-in-TAV) and explant

14 Feb 2026 – From PCR Tokyo Valves 2026

This session offers an in-depth exploration of lifetime management strategies for patients undergoing Evolut first redo TAVI procedures, including TAV-in-TAV and explant techniques. It provides a comprehensive understanding of clinical decision-making algorithms, technical challenges, and key considerations for successful procedural planning and execution, supported by real-world...

Learn from the experts: lifetime management for Evolut first redo TAVI (TAV-in-TAV) and explant

Design that delivers the future of TAVI

13 Feb 2026 – From PCR Tokyo Valves 2026

This session presents the future of TAVI valve design, emphasizing supra-annular valve benefits, strategies for managing concomitant coronary artery disease, and redo-TAVI approaches tailored for long-term patient management.

Design that delivers the future of TAVI

Mastering techniques from basic to complex - TAVI basics

13 Feb 2026 – From PCR Tokyo Valves 2026

This session offers a comprehensive overview of Transcatheter Aortic Valve Implantation (TAVI) fundamentals, focusing on CT scan analysis for optimal patient and valve selection, strategies to avoid procedural complications, and approaches to streamline TAVI procedures for improved outcomes.

Mastering techniques from basic to complex - TAVI basics

Mastering techniques from basic to complex - Avoidance and management of TAVI complications

13 Feb 2026 – From PCR Tokyo Valves 2026

Address the challenges posed by complex TAVI complications through expert discussion on prevention, management, and bailout techniques. This session covers critical complications such as annulus rupture, stroke, conduction disturbances, and vascular events.

Mastering techniques from basic to complex - Avoidance and management of TAVI complications

Mastering techniques from basic to complex - Advanced TAVI

13 Feb 2026 – From PCR Tokyo Valves 2026

Explore advanced TAVI topics including valve selection for small annuli, optimization strategies for bicuspid aortic valve interventions, and techniques ensuring safety and efficacy in valve-in-valve procedures.

Mastering techniques from basic to complex - Advanced TAVI

Revisiting aortic valve replacement in light of the new ESC/EACTS guidelines

04 Feb 2026

Dive into a webinar uncovering how cardiac CT is transforming the evaluation and lifetime management of severe aortic stenosis—from sharper diagnostics to smarter valve choices.

Revisiting aortic valve replacement in light of the new ESC/EACTS guidelines

How to close vascular access with a combined suture-/plug-based strategy using one ProStyle and one Angio-Seal in TAVI

29 Jan 2026

Large-bore femoral access closure remains a critical step in transfemoral TAVI, where access-site complications can significantly impact outcomes.

This My Toolkit article presents a step-by-step tutorial on a combined suture- and plug-based closure strategy using one ProStyle™ and one Angio-Seal®. The technique aims to achieve rapid, reliable...

Akiko Masumoto

Author

Akiko Masumoto

Author

Chiara De Biase
How to close vascular access with a combined suture-/plug-based strategy using one ProStyle and one Angio-Seal in TAVI

A challenging valve-in-valve scenario in a patient with prior aortic coarctation repair

02 Feb 2026

This case features a 79-year-old patient with severe aortic stenosis and a degenerated surgical bioprosthesis, who previously underwent complex aortic surgery for coarctation.

Redo surgery was high-risk, so a transcatheter valve-in-valve procedure was chosen.

Explore the case to see how anatomy, prosthesis sizing, and vascular access options guide...

Ana Paula Tagliari

Author

Ana Paula Tagliari
Rodrigo Saadi

Author

Rodrigo Saadi
Eduardo Saadi

Author

Eduardo Saadi
Álvaro Schmidt Albrecht

Author

Álvaro Schmidt Albrecht
Marcelo Miglioranza

Author

Marcelo Miglioranza
A challenging valve-in-valve scenario in a patient with prior aortic coarctation repair

Overcoming complexity in TAVI: a patient-centered approach

12 Jan 2026

Discover how to overcome complexity in TAVI, in this replay featuring H. Möllmann and guests R. Hahn, W-K. Kim and P. Lauten.

Overcoming complexity in TAVI: a patient-centered approach

Fractional flow reserve to guide revascularisation in patients with coronary artery disease undergoing TAVR

07 Jan 2026

The present analysis compared major adverse cardiac events in patients with significant coronary stenosis (FFR ≤ 0.80 or visual stenosis ≥ 90 %) versus those with non-significant stenosis (FFR > 0.80).

Ruxandra Sava

Reviewer

Ruxandra Sava
Alessandro Sticchi

Reviewer

Alessandro Sticchi
Fractional flow reserve to guide revascularisation in patients with coronary artery disease undergoing TAVR

How to manage Safari wire entrapment during TAVI with Navitor THV

19 Jan 2026

Safari wire entrapment during TAVI is a rare but potentially serious complication, particularly with sheathless self-expanding valves. In this My Toolkit article, we describe a simple, effective technique using a parallel stiff guidewire to safely retrieve both the catheter and the entrapped Safari wire when performing...

Mauro Boiago

Author

Mauro Boiago
Neila Sayah

Author

Neila Sayah
Stéphane Champagne

Author

Stéphane Champagne

Author

Antoinette Neylon
How to manage Safari wire entrapment during TAVI with Navitor THV